Stem Cell-Derived Compositions for Fat Decomposition and Muscle Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceutical and cosmetic compositions face challenges in effectively utilizing stem cells and stem cell culture media, particularly due to immune rejection and ethical concerns associated with embryonic stem cells, as well as the limited efficacy of existing compositions in addressing various health issues.
Innovation Solution
The development of pharmaceutical and cosmetic compositions that incorporate stem cells, extracts of stem cells, stem cell culture media, supernatants from stem cell induction, and secretions from stem cells, which can be used to create agents for various therapeutic and cosmetic applications, such as fat decomposition, anti-obesity, muscle formation, and joint health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If embryonic stem cells are used for transplantation therapy, then therapeutic effects are improved, but immune rejection reactions occur and ethical issues arise
Solution Approach 1:
The patent uses induced pluripotent stem cells (iPS cells) as a copy or alternative to embryonic stem cells. iPS cells are generated by reprogramming adult somatic cells to express pluripotency, creating a functional equivalent that avoids the ethical and immune rejection issues of embryonic stem cells while maintaining therapeutic efficacy
2Reliability
If embryonic stem cells are used for transplantation therapy, then therapeutic effects are improved, but ethical criticism and opposition occur
Solution Approach 1:
The patent replaces embryonic stem cells with induced pluripotent stem cells (iPS cells) that are generated by reprogramming adult somatic cells. This copying approach maintains the therapeutic benefits of pluripotent stem cells while eliminating the ethical controversy associated with destroying human embryos
3Productivity
If stem cell culture medium is reused in pharmaceutical compositions, then resource utilization is improved, but contamination risks and efficacy limitations occur
Solution Approach 1:
The patent extracts and isolates specific bioactive components (such as growth factors, cytokines, and metabolites) from the stem cell culture medium. By separating these useful components from the complex medium mixture, the patent enables their controlled use in pharmaceutical compositions, ensuring both resource utilization and reliable efficacy without contamination risks
Data Source
AI summary
Problem to be SolvedTo provide pharmaceutical compositions and cosmetic compositions that effectively utilize a stem cell and stem cell culture media.SolutionA fat-decomposing agent, agent for promoting differentiation induction of a myotube from a myoblast, prostacyclin production promoter, hyaluronic acid production promoter for a chondrocyte, anti-aging agent, agent for treating or preventing a lifestyle-related disease, or agent for treating or preventing an adult disease, each comprising a stem cell, an extract of a stem cell, a medium of a stem cell, a supernatant of a culture medium during stem cell induction, a supernatant of a culture medium of stem cells, or a secretion of a stem cell.